In people using Zepbound, hair loss occurred more frequently in females (7.1%) than in males (0.5%), but no patients using Zepbound stopped studies due to hair loss
This deep dive covers the clinical evidence, mechanisms, who benefits most, and how to approach a PMOS fertility metabolic plan.
Its effect on appetite and weight loss became apparent during clinical trials
The end result is a chance to maximize the health benefits of GLP-1 obesity treatments (which have enormous potential) while containing risks and costs through data-driven insights
A food can be excellent on paper and useless in real life if nobody wants to wash, chop, or cook it on a Wednesday night
They are not a magic solution weight loss still comes down to burning more calories than you consume